Tilray Brands Inc header image

Tilray Brands Inc

TLRY

Equity

ISIN null / Valor 42386407

NASDAQ (2026-02-26)
USD 7.99+2.04%

Tilray Brands Inc
UMushroom community rating:

star star star star star
2.50 2 votes No rating yet
NegativeNeutralPositive

About company

Tilray Brands Inc. is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids. The company prides itself on a scientific approach to product development, emphasizing active ingredients, standardized preparations, and consistent, measured dosing. Tilray's product portfolio is rigorously tested for potency and purity, ensuring high-quality offerings across various categories, including medicinal and recreational cannabis. Under the leadership of CEO Irwin D. Simon, who has over 30 years of experience in building consumer packaged goods companies, Tilray has positioned itself as a leader in the global cannabis market. Simon's previous success in transforming Aphria Inc. into a profitable entity and his foundational role at The Hain Celestial Group highlight his capability to steer Tilray towards significant growth and market share. The company's operational excellence spans from cultivation to shipping, with a focus on precision, professionalism, and care at every stage of the process, aiming to deliver unparalleled products to its patients and consumers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

0.20%1Y
-71.7%3Y
-96.7%5Y

Performance

126%1Y
96.9%3Y
93.3%5Y

Volatility

Market cap

931 M

Market cap (USD)

Daily traded volume (Shares)

2,187,078

Daily traded volume (Shares)

1 day high/low

1.415 / 1.33

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

2.50

2 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
2.50
Nature:
starstarstarstarstar
2.50
Robin Roten
Switzerland, 04 Dec 2022
star star star star star
Tej Ram Kumpakha
Switzerland, 25 Mar 2022
star star star star star
Though the company is not successful yet to achieve the positive net profit; the share price is likely to increase mainly due the House Rules Committee voting on legalizing Cannabis.

EQUITIES OF THE SAME SECTOR

Vita 34 AG
Vita 34 AG Vita 34 AG Valor: 2333201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 5.20
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.06%EUR 0.95
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.70%USD 22.70
iRhythm Technologies Inc
iRhythm Technologies Inc iRhythm Technologies Inc Valor: 34117792
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.15%USD 140.18
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.31%CHF 128.10
Savaria Corp
Savaria Corp Savaria Corp Valor: 1385257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%CAD 25.72
Johnson & Johnson
Johnson & Johnson Johnson & Johnson Valor: 943981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%USD 243.47
Novo Nordisk A/S
Novo Nordisk A/S Novo Nordisk A/S Valor: 461641
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.42%USD 37.62
Merck & Co Inc
Merck & Co Inc Merck & Co Inc Valor: 10683053
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.58%USD 119.30
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%USD 27.10